No information is available on the use of elagolix during breastfeeding. Because elagolix is 80% bound to plasma proteins, the amount in milk is likely to be low. However, because no information is available on the use of elagolix during breastfeeding caution should be used, especially while nursing a newborn or preterm infant.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Substance Identification
Substance Name
Elagolix
CAS Registry Number
834153-87-6
Drug Class
Breast Feeding
Lactation
Milk, Human
GnRH Receptor Antagonists
Gonadotropin-Releasing Hormone Antagonists
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
